The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

Autor: Borges da Silva, Fernanda 1, 2, de Figueiredo-Pontes, Lorena Lobo 1, 2, Madeira, Maria Isabel Ayrosa 1, 2, Corrêa de Araujo Koury, Luisa 1, 2, Gouvêa de Lima, Ana Silvia 1, 2, Santos Scheucher, Priscila 1, 2, Coelho-Silva, Juan Luiz 1, 2, Pagnano, Katia Borgia Barbosa 3, Pallota, Ronald 4, de Lourdes Chauffaille, Maria 5, Oltramari, Marcos Roberto Pedron 6, Bittencourt, Rosane Isabel 7, Higashi, Marcia 8, Bendlin, Rodrigo Miguel 9, Rodrigues Pereira Velloso, Elvira Deolinda 10, 11, Lowenberg, Bob 12, Ganser, Arnold 13, Berliner, Nancy 14, Valk, Peter 12, Magalhães Rego, Eduardo 1, 2, Traina, Fabiola 1, 2, *
Zdroj: In Blood Advances 8 December 2017 1 Supplement:86-89
Databáze: ScienceDirect